Spike seen in prices of several Rx pain drugs

Share this article:

Dozens of prescription painkillers are up to 15 percent more costly since last year's withdrawal of Vioxx, according to a report from Consumers Union.
The Consumer Reports Best Buy Drugs report says price increases were seen among 36 pain drugs, along with growth in prescribing volume among NSAIDs (nonsteroidal anti-inflammatory drugs). Among them, prices for prescription strength Motrin, from Johnson & Johnson's McNeil-PPC, climbed 13.3 percent and Boehringer Ingelheim's Mobic, marketed in the U.S. by Abbott, jumped 10.6 percent.
Based on data from NDCHealth, the report also says 17 drugs dropped in price, and 10 remained flat.OTC medicines were not included. Merck pulled Vioxx in September after studies linked the COX-2 drug to heart problems.

 

Share this article:

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.